Stay updated on Phase II Pembrolizumab Plus GVD Clinical Trial
Sign up to get notified when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.

Latest updates to the Phase II Pembrolizumab Plus GVD Clinical Trial page
- Check7 days agoChange DetectedISRT sections were added (PART 3A/3B) with reference to ISRT guidelines for nodal disease. Eligibility criteria were updated to specify PET-based Lugano measurable disease and autoimmune disease exclusions, and the study endpoints include a 5-year disease-free survival assessment.SummaryDifference1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page metadata was updated to reflect a new revision (v3.6.3) and more recent update dates (2026-06-26 and 2026-06-29), indicating an administrative update to the study record.SummaryDifference0.2%

- Check28 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a software update to the page. No changes to the displayed study details or layout are evident from this revision.SummaryDifference0.0%

- Check35 days agoChange DetectedNew update dates (2026-06-17, 2026-06-16, 2026-06) were added and older dates (2026-04-16, 2026-04-13, 2026-04) were removed from the update history, signaling recent activity on the study page.SummaryDifference0.2%

- Check42 days agoChange DetectedNew helper links were added to the study page (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and the page’s revision tag was updated to v3.6.0; the Intervention heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.4%

- Check49 days agoChange DetectedThe page's revision label has been updated to v3.5.5, indicating a recent deployment of site updates.SummaryDifference0.0%

Stay in the know with updates to Phase II Pembrolizumab Plus GVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.